Gruppo Italiano per lo Studio della Streptochinasi nell'Infarcto Miocardico (GISSI).Long-term effects of intravenous thrombolysis in acute myocardial infarction: Final report of the GISSI study. Lancet1987; i: 871–74.
2.
WilcoxRGOlssonCGSkeneAMvon der LippeGJensenGHamptonJR. For the ASSET study group. Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET). Lancet1988; ii: 525–30.
3.
AbbottWMMcCabeCMaloneyRDWirthlinLS. Embolism of the popliteal artery. Surg Gynecol Obstet1984; 159: 533–36.
4.
AmeryADeloofWVermylenJVerstraeteM.Outcome of recent thromboembolic occlusions of limb arteries treated with streptokinase. Br Med J1970; 9: 639–44.
5.
FiessingerJNAiachMLagneauPHussonJMCormierJM. Indications de la streptokinase dans les obliterations arterielle de membres. Coeur Med1976; 15: 453–59.
6.
MackayIRNimmoMWalkerMBelchJJF. Results of a pilot study of intravenous rtPA (Actilyse) in acute peripheral arterial occlusion. Proceedings of the Royal Society for Medicine Forum on Angiology, 6 March 1992.
7.
McNicolGPReidWBainWHDouglasAS. Treatment of peripheral arterial occlusion by streptokinase perfusion. Br Med J1963; i: 1508–509.
VerstraeteM.Use of thrombolytic drugs in noncoronary disorders. Drugs1989; 38: 801–21.
10.
McNamaraTOFischerJR. Thrombolysis of peripheral arterial and graft occlusions: Improved results using high dose urokinase. Am J Roentgenol1985; 144: 769–75.
11.
GraorRARisiusBYoungJRGreisingerMAZeichMG. Low dose streptokinase for selective thrombolysis: Systemic effects and complications. Radiology1984; 152: 35–39.
12.
GallusAS. The use of antithrombotic drugs in artery disease. Clin Haematol1986; 15: 509–59.
13.
RicottaJJGreenRMDeWeeseJA. Use and limitations of thrombolytic therapy in the treatment of peripheral arterial ischaemia: Results of a multi-institutional questionnaire. J Vasc Surg1987; 6: 46–50.
14.
HessHIngrischHMietaschkARathH.Local low-dose thrombolytic therapy of peripheral arterial occlusions. N Engl J Med1982; 307: 1627.
15.
HessHMietaschkABrucklR.Peripheral arterial occlusions: A 6-year experience with local low-dose thrombolytic therapy. Radiology1987; 163: 753–58.
16.
GraorRAOlinJW. Regional thrombolysis in peripheral arterial occlusions. In: JulianDKublerWNorrisRMSwanHJCCollenDVerstraeteM eds. Thrombolysis in cardiovascular disease. Basel: Dekker, 1989: 381–95.
17.
GardinerGAHarringtonDPKultunWWhitemoreAMannickJALevinDC. Salvage of occluded arterial bypass graft by means of thrombolysis. J Vasc Surg1989; 9: 426–31.
18.
EarnshawJJGregsonRHSMakinGSHopkinsonBR. Early results of low dose intra-arterial streptokinase therapy in acute and subacute lower limb arterial ischaemia. Br J Surg1987; 74: 504–507.
19.
LangEK. Streptokinase therapy: Complications of intra-arterial use. Radiology1985; 154: 75–77.
20.
VerstraeteMHessHMahlerFMietaschkARothFSchneiderEBaertAVerhaegheR.Femoro-popliteal artery thrombolysis with intra-arterial infusion of recombinant tissue-type plasminogen actvator-report of a pilot trial. Eur J Vasc Surg1988; 2: 155–59.
GraorRARisiusBLucasFV. Thrombolysis with recombinant human tissue-type plasminogen activator in patients with peripheral artery and by-pass graft occlusions. Circulation1986; 74: 15–20.
23.
EarnshawJJWestbyJCGregsonRHSMakinGSHopkinsonBR. Local thrombolytic therapy of acute peripheral arterial ischaemia with tissue plasminogen activator: A dose ranging study. Br J Surg1988; 75: 1196–2000.
24.
MeyerovitzMFGoldhaberSZReaganK.Recombinant tissue-type plasminogen activator versus urokinase in peripheral arterial and graft occlusions: A randomised trial. Radiology1990; 175: 75–78.
25.
EarnshawJJWestbyJCMarkinGSHopkinsonBR. The systemic fibrinolytic effect of BRL.26921 during the treatment of acute peripheral arterial occlusions. Thromb Haemost1986; 55: 259–62.